BNTX

BioNTech SE - ADR

119.34

USD

BNTX Earnings Reports

Positive Surprise Ratio

BNTX beat 17 of 25 last estimates.

68%

Next Report

Date of Next Report

Mar 10, 2026

Estimate for Q4 25 (Revenue/ EPS)

$817.57M

-$0.02

Implied change from Q3 25 (Revenue/ EPS)

-46.17%

-83.33%

Implied change from Q4 24 (Revenue/ EPS)

-31.30%

-101.85%

BioNTech SE - ADR earnings per share and revenue

On Nov 03, 2025, BNTX reported earnings of -0.12 USD per share (EPS) for Q3 25, beating the estimate of -0.21 USD, resulting in a 44.42% surprise. Revenue reached 1.52 billion, compared to an expected 979.55 million, with a 55.06% difference. The market reacted with a +0.04% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 18 analysts forecast an EPS of -0.02 USD, with revenue projected to reach 817.57 million USD, implying an decrease of -83.33% EPS, and decrease of -46.17% in Revenue from the last quarter.

FAQ

What were BioNTech SE - ADR's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, BioNTech SE - ADR reported EPS of -$0.12, beating estimates by 44.42%, and revenue of $1.52B, 55.06% above expectations.

How did the market react to BioNTech SE - ADR's Q3 2025 earnings?

The stock price moved up 0.04%, changed from $103.91 before the earnings release to $103.95 the day after.

When is BioNTech SE - ADR expected to report next?

The next earning report is scheduled for Mar 10, 2026.

What are the forecasts for BioNTech SE - ADR's next earnings report?

Based on 18 analysts, BioNTech SE - ADR is expected to report EPS of -$0.02 and revenue of $817.57M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.